This inventor holds 4 USPTO granted patents. Top assignees: Merck + Co., Inc., Other. Active years: 1999-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 4,770 
1 out of 834,601 Years Active: 1999-2002
Title: Ilias K Dorziotis: Innovator in Pharmaceutical Chemistry
Introduction
Ilias K Dorziotis is a notable inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on innovative processes that enhance the efficacy of pharmaceutical compounds.
Latest Patents
Dorziotis's latest patents include the "Diastereoselective preparation of Michael adducts," which describes a Michael addition conducted in the presence of a zinc-amine complex. This method results in products with high diastereomeric excess. Another significant patent is the "Process for making phenyl heterocycles useful as COX-2 inhibitors," which encompasses a process for creating compounds that are beneficial in treating cyclooxygenase-2 mediated diseases.
Career Highlights
Throughout his career, Ilias K Dorziotis has worked with prominent companies, including Merck & Company, Inc. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Dorziotis has collaborated with esteemed colleagues such as Ioannis N Houpis and Ralph P Volante. These partnerships have contributed to the advancement of his research and the successful development of his patented processes.
Conclusion
Ilias K Dorziotis stands out as a significant figure in pharmaceutical innovation, with a focus on enhancing drug efficacy through his patented processes. His contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile